Consumer Health in France

TABLE OF CONTENTS

List Of Contents And Tables

EXECUTIVE SUMMARY

• Consumer health in 2024: The big picture
• 2024 key trends
• Competitive landscape
• Retailing developments
• What next for consumer health?

MARKET INDICATORS

• Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
• Table 2 Life Expectancy at Birth 2019-2024

MARKET DATA

• Table 3 Sales of Consumer Health by Category: Value 2019-2024
• Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
• Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
• Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
• Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
• Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
• Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
• Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
• Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029

APPENDIX

• OTC registration and classification
• Vitamins and dietary supplements registration and classification
• Self-medication/self-care and preventive medicine
• Switches

DISCLAIMER

DEFINITIONS

SOURCES

• Summary 1 Research Sources

ANALGESICS IN FRANCE

KEY DATA FINDINGS

2024 DEVELOPMENTS

• Analgesics beset by challenges in 2024
• Despite the popularity of acetaminophen, ibuprofen's woes erode overall category potential
• Doliprane's popularity consolidates Sanofi's leadership position, while consumers fret over dearth of medical professionals

PROSPECTS AND OPPORTUNITIES

• Self-medication on the rise, but uncertainty around pseudoephedrine dampens expectations for overall category
• Retailers and manufacturers look to avoid shortages
• Sanofi to divest itself of consumer health arm

CATEGORY DATA

• Table 12 Sales of Analgesics by Category: Value 2019-2024
• Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
• Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
• Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
• Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
• Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN FRANCE

KEY DATA FINDINGS

2024 DEVELOPMENTS

• 2024 sees modest sales performance
• Combination products witness another year of double-digit decline amid pseudoephedrine controversy
• Ricola benefits from French consumers' sweet tooth

PROSPECTS AND OPPORTUNITIES

• As flu seasons settle down the impact will be offset by rising demand for antihistamines/allergy remedies
• More innovation necessary amid intensifying competition, while ageing population will help to sustain sales
• Growing preference among local consumers for natural remedies

CATEGORY DATA

• Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
• Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
• Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
• Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
• Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
• Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029

DIGESTIVE REMEDIES IN FRANCE

KEY DATA FINDINGS

2024 DEVELOPMENTS

• Robust growth results from consumer stress and sharp price hikes
• Tourism boost helps motion sickness remedies, while Johnson & Johnson leads by a slight margin
• Focus on gut health and demand for probiotics present challenge to growth

PROSPECTS AND OPPORTUNITIES

• Stress and ageing to maintain future category growth
• PPIs faces concerns over possible product misuse
• Natural alternatives pose threat to OTC remedies

CATEGORY DATA

• Table 24 Sales of Digestive Remedies by Category: Value 2019-2024
• Table 25 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
• Table 26 NBO Company Shares of Digestive Remedies: % Value 2020-2024
• Table 27 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
• Table 28 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
• Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029

DERMATOLOGICALS IN FRANCE

KEY DATA FINDINGS

2024 DEVELOPMENTS

• Dermatologicals deemed less important than other OTC offerings during times of financial uncertainty
• Growth driven by return to pre-pandemic patterns
• Stress and anxiety boost performance of hair loss treatments

PROSPECTS AND OPPORTUNITIES

• Demographic and climate issues set to impact forecast performance
• Continuous challenge from unclear positioning for dermatologicals
• Under-exploited potential for vaginal antifungals, while medicated shampoos will maintain stable sales

CATEGORY DATA

• Table 30 Sales of Dermatologicals by Category: Value 2019-2024
• Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024
• Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024
• Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024
• Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2021-2024
• Table 35 Forecast Sales of Dermatologicals by Category: Value 2024-2029
• Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029

NRT SMOKING CESSATION AIDS IN FRANCE

KEY DATA FINDINGS

2024 DEVELOPMENTS

• Reimbursement remains key for category, limiting OTC penetration
• Oral formats dominate, while players focus on mobile apps
• Leading players take divergent approaches to boosting sales

PROSPECTS AND OPPORTUNITIES

• Category will struggle over the forecast period
• E-vapour products remain a serious competitive threat
• Natural products unlikely to make any headway in NRT smoking cessation aids

CATEGORY INDICATORS

• Table 37 Number of Smokers by Gender 2019-2024

CATEGORY DATA

• Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
• Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024
• Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2020-2024
• Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2021-2024
• Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2024-2029
• Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2024-2029

SLEEP AIDS IN FRANCE

KEY DATA FINDINGS

2024 DEVELOPMENTS

• Sleep aids continues to reap benefits from consumer stress and anxiety
• Gummies gain rapid ground
• Sanofi's Novanuit remains overall leader

PROSPECTS AND OPPORTUNITIES

• Demand set to continue throughout forecast period, despite challenges ahead
• Possible new competition from other consumer health options
• Potential for expansion in sea magnesium, melatonin and CBD

CATEGORY DATA

• Table 44 Sales of Sleep Aids: Value 2019-2024
• Table 45 Sales of Sleep Aids: % Value Growth 2019-2024
• Table 46 NBO Company Shares of Sleep Aids: % Value 2020-2024
• Table 47 LBN Brand Shares of Sleep Aids: % Value 2021-2024
• Table 48 Forecast Sales of Sleep Aids: Value 2024-2029
• Table 49 Forecast Sales of Sleep Aids: % Value Growth 2024-2029

EYE CARE IN FRANCE

KEY DATA FINDINGS

2024 DEVELOPMENTS

• Increase in pollen and airborne allergens boost category performance
• Modern lifestyles also aid performance
• Competitive landscape remains stable

PROSPECTS AND OPPORTUNITIES

• Rising prevalence of myopia in France
• Demand for eye care to forge ahead over the forecast period
• OTC eye care evolves amid ophthalmologist shortages

CATEGORY DATA

• Table 50 Sales of Eye Care by Category: Value 2019-2024
• Table 51 Sales of Eye Care by Category: % Value Growth 2019-2024
• Table 52 NBO Company Shares of Eye Care: % Value 2020-2024
• Table 53 LBN Brand Shares of Eye Care: % Value 2021-2024
• Table 54 Forecast Sales of Eye Care by Category: Value 2024-2029
• Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2024-2029

WOUND CARE IN FRANCE

KEY DATA FINDINGS

2024 DEVELOPMENTS

• Poor performance for wound care in 2024
• URGO maintains leadership of overall wound care
• Ongoing threat to pharmacies from grocery retail

PROSPECTS AND OPPORTUNITIES

• Maturity contributes to forecast disappointing performance
• Pure online and private label players hold further growth potential
• Limited room for growth in products with value-added features

CATEGORY DATA

• Table 56 Sales of Wound Care by Category: Value 2019-2024
• Table 57 Sales of Wound Care by Category: % Value Growth 2019-2024
• Table 58 NBO Company Shares of Wound Care: % Value 2020-2024
• Table 59 LBN Brand Shares of Wound Care: % Value 2021-2024
• Table 60 Forecast Sales of Wound Care by Category: Value 2024-2029
• Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2024-2029

VITAMINS IN FRANCE

KEY DATA FINDINGS

2024 DEVELOPMENTS

• Return to pre-pandemic trends for vitamins in France
• Multivitamins too expensive for many, as vitamin D recovers from previous year's dip
• Bayer rises in 2024

PROSPECTS AND OPPORTUNITIES

• Growth set to continue during forecast period, benefitting from dietary trends
• Multivitamin growth to stay stable
• Vitamin D recommendation expected to accelerate growth

CATEGORY DATA

• Table 62 Sales of Vitamins by Category: Value 2019-2024
• Table 63 Sales of Vitamins by Category: % Value Growth 2019-2024
• Table 64 Sales of Multivitamins by Positioning: % Value 2019-2024
• Table 65 NBO Company Shares of Vitamins: % Value 2020-2024
• Table 66 LBN Brand Shares of Vitamins: % Value 2021-2024
• Table 67 Forecast Sales of Vitamins by Category: Value 2024-2029
• Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2024-2029

DIETARY SUPPLEMENTS IN FRANCE

KEY DATA FINDINGS

2024 DEVELOPMENTS

• Another strong year of growth as consumers continue to opt for natural fixes
• Category-wide dynamism is thanks to the promise of functional ingredients
• Dermapharm leads while BMS enters the category with innovative offering

PROSPECTS AND OPPORTUNITIES

• Favourable outlook thanks to increased focus on more natural products
• Social media activity expected to drive growth
• Pharmacies likely to reinforce leadership, as players focus more on benefits of eye health products

CATEGORY DATA

• Table 69 Sales of Dietary Supplements by Category: Value 2019-2024
• Table 70 Sales of Dietary Supplements by Category: % Value Growth 2019-2024
• Table 71 Sales of Dietary Supplements by Positioning: % Value 2019-2024
• Table 72 NBO Company Shares of Dietary Supplements: % Value 2020-2024
• Table 73 LBN Brand Shares of Dietary Supplements: % Value 2021-2024
• Table 74 Forecast Sales of Dietary Supplements by Category: Value 2024-2029
• Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2024-2029

WEIGHT MANAGEMENT AND WELLBEING IN FRANCE

KEY DATA FINDINGS

2024 DEVELOPMENTS

• Weight management and wellbeing continues to suffer in 2024
• Evolving demand undermines interest in traditional category products
• Detox, drainage and gummies

PROSPECTS AND OPPORTUNITIES

• Category faces difficult road ahead
• Customised coaching and new approaches
• Ongoing development for supplement nutrition and slimming teas

CATEGORY DATA

• Table 76 Sales of Weight Management and Wellbeing by Category: Value 2019-2024
• Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024
• Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2020-2024
• Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2021-2024
• Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2024-2029
• Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2024-2029

SPORTS NUTRITION IN FRANCE

KEY DATA FINDINGS

2024 DEVELOPMENTS

• Growth driven rising numbers of athletes interested in endurance sports and fitness
• Explosion of gyms versus running and home-based training
• Mainstream players face a new generation of competitors

PROSPECTS AND OPPORTUNITIES

• Plenty of room for growth in a still-evolving market
• Players to focus on finding new target audiences
• Anticipated influx of new products and formats

CATEGORY DATA

• Table 82 Sales of Sports Nutrition by Category: Value 2019-2024
• Table 83 Sales of Sports Nutrition by Category: % Value Growth 2019-2024
• Table 84 NBO Company Shares of Sports Nutrition: % Value 2020-2024
• Table 85 LBN Brand Shares of Sports Nutrition: % Value 2021-2024
• Table 86 Forecast Sales of Sports Nutrition by Category: Value 2024-2029
• Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2024-2029

HERBAL/TRADITIONAL PRODUCTS IN FRANCE

KEY DATA FINDINGS

2024 DEVELOPMENTS

• French consumers continue to shift towards herbal/traditional products
• Sleep issues and stress support sales, as natural trends gain traction
• Dermapharm as leading GBO through acquisition of Laboratoires Arkopharma, and demand for CBD-based variants rises rapidly

PROSPECTS AND OPPORTUNITIES

• Ongoing favourable outlook for herbal/traditional products
• NRT smoking cessation aids unlikely to be impacted by herbal and natural trends
• Rising digestive complaints will support further category growth

CATEGORY DATA

• Table 88 Sales of Herbal/Traditional Products by Category: Value 2019-2024
• Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2019-2024
• Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2020-2024
• Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2021-2024
• Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2024-2029
• Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2024-2029

PAEDIATRIC CONSUMER HEALTH IN FRANCE

KEY DATA FINDINGS

2024 DEVELOPMENTS

• Ambivalent performance from paediatric consumer health in 2024
• Non-chemical lice treatments gain momentum
• Naturalness trend spreads throughout overall category

PROSPECTS AND OPPORTUNITIES

• Changing demographics present challenges to growth
• Rising demand for paediatric vitamins and dietary supplements with natural positioning
• Paediatric consumer health to be further affected by shortages

CATEGORY DATA

• Table 94 Sales of Paediatric Consumer Health by Category: Value 2019-2024
• Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
• Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2020-2024
• Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2021-2024
• Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029
• Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029